1887

Chapter 30 : Pathology and Pathogenesis of Virus Infections

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Pathology and Pathogenesis of Virus Infections, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555816872/9781555815141_Chap30-1.gif /docserver/preview/fulltext/10.1128/9781555816872/9781555815141_Chap30-2.gif

Abstract:

While the term immunopathology was originally used to describe an aberrant immune response to autoantigen resulting in pathology, more recent developments in our understanding of virus-induced immunopathology have revealed that this can be linked to both an aberrant immune response to the virus itself as well as unfavorable virus-induced changes to the immune response as a whole; for example, lymphopenia following certain types of infections as well as the specific loss of CD4 T cells in HIV infection. Perhaps the most common virus-induced pathology is T-cell-induced destruction of host tissues. T-cell mediated pathologies occur through both direct and indirect mechanisms including the targeted cytolysis of the infected cell by effector T cells, the induction of apoptosis in infected cells and generalized tissue damage due to bystander effects of T-cell activation. Difficulties in establishing an animal model of hantavirus pulmonary syndrome (HPS) had greatly hampered progress in understanding the factors involved in pathogenesis. Perhaps the most widely examined example of antibody dependent enhancement (ADE) can be found in dengue virus infections. The process by which viruses may induce or enhance autoimmunity is hypothesized to occur by a number of mechanisms. Recent clinical trials for several different vaccines, where vaccinated groups had elevated risk for infection and or disease than their naive cohorts, have highlighted the necessity for continued basic science research into the precise mechanisms of virus-induced immunopathology. One example of this can be found in the vastly different outcomes achieved with different strategies in respiratory syncytial virus (RSV) vaccination.

Citation: Jones C, Von Herrath M. 2011. Pathology and Pathogenesis of Virus Infections, p 383-389. In Kaufmann S, Rouse B, Sacks D (ed), The Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555816872.ch30

Key Concept Ranking

Tumor Necrosis Factor alpha
0.4528104
Acute Respiratory Distress Syndrome
0.44924498
Sin nombre virus
0.44276398
Lymphocytic choriomeningitis virus
0.42595017
0.4528104
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Model of antibody-dependent enhancement of viral infection. In the absence of antibody, receptors on the surface of the virion attach to the cell via interactions with the cognate receptor on the surface of the cell, followed by adsorption of the virus into the host cell (A). In the presence of sufficient concentration of neutralizing antibody, viral adsorption or attachment of the virus to the cell is blocked (B). The presence of subneutralizing (either heterotypic or insufficient titer of neutralizing) preexisting antibody may enhance viral attachment or adsorption to the surface of Fc-receptor bearing cells. Alternatively, the simultaneous engagement Fc receptors on the surface of an infected cell may enhance the ability of the virus to replicate in Fc receptor bearing cells downstream of attachment and adsorption or alter the function of the infected APC (C).

Citation: Jones C, Von Herrath M. 2011. Pathology and Pathogenesis of Virus Infections, p 383-389. In Kaufmann S, Rouse B, Sacks D (ed), The Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555816872.ch30
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555816872.ch30
1. Abel Borges, A., and, L. T. Figueiredo. 2008. Mechanisms of shock in hantavirus pulmonary syndrome. Curr. Opin. Infect. Dis. 21:293297.
2. Banerjee, K.,, P. S. Biswas,, B. Kim,, S. Lee, and, B. T. Rouse. 2004. CXCR2–/— mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 172:12371245.
3. Banerjee, K.,, P. S. Biswas, and, B. T. Rouse. 2005. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J. Leukoc. Biol. 77:2432.
4. Banerjee, K.,, S. Deshpande,, M. Zheng,, U. Kumaraguru,, S. P. Schoenberger, and, B. T. Rouse. 2002. Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol. 219:108118.
5. Beaumier, C. M., and, A. L. Rothman. 2009. Cross-reactive memory CD4+ T cells alter the CD8+ T-cell response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. Viral Immunol. 22:215219.
6. Bettelli, E.,, T. Korn,, M. Oukka, and, V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453:10511057.
7. Bettelli, E.,, M. Oukka, and, V. K. Kuchroo. 2007. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8:345350.
8. Buchmeier, M. J., and, M. B. Oldstone. 1978. Virus-induced immune complex disease: identification of specific viral antigens and antibodies deposited in complexes during chronic lymphocytic choriomeningitis virus infection. J. Immunol. 120:12971304.
9. Dakhama,, A.,, Y. M. Lee,, H. Ohnishi,, X. Jing,, A. Balhorn,, K. Takeda, and, E. W. Gelfand. 2009. Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J. Allergy Clin. Immunol. 123:138145.
10. Deshpande, S.,, K. Banerjee,, P. S. Biswas, and, B. T. Rouse. 2004. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev. Mol. Med. 6:114.
11. Deshpande, S.,, M. Zheng,, S. Lee,, K. Banerjee,, S. Gangappa,, U. Kumaraguru, and, B. T. Rouse. 2001. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 167:29022910.
12. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337348.
13. Filippi, C. M., and, M. G. von Herrath. 2008. Viral trigger for type 1 diabetes: pros and cons. Diabetes 57:28632871.
14. Flint, S. J.,, Enquist,, L.W., Racaniello,, V. R. and Skalka,, A. M. 2004. Virus offense meets host defense, p. 530–595. In Principles of Virology, 2nd ed. ASM Press, Washington, D.C.
15. Gangappa, S.,, J. S. Babu,, J. Thomas,, M. Daheshia, and, B. T. Rouse. 1998. Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition. J. Immunol. 161:42894300.
16. Gubler, D. J. 1997. Dengue and Dengue hemorrhagic fever: its history and resurgence as a global public health problem, p. 1–22. In D. J. Gubler and Kuno, G. (ed.), Dengue and Dengue Hemorrhagic Fever. CAB International, Oxford.
17. Gubler, D. J., Kuno, and, G., Markoff,, L. 2007. Flaviviruses, p. 1153–1252. In D. M. Knipe and P. M. Howley (ed.), Fields Virology, 5th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia.
18. Hou, W.,, H. S. Kang, and, B. S. Kim. 2009. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J. Exp. Med. 206:313328.
19. Janeway, C. A., Travers,, P., Walport,, M., Shlomchik,, M. J. 2001. The humoral immune response, p. 341–380. In Immunobiology, 5th ed. Garland Publishing, New York.
20. Kapikian,, A. Z.,, R. H. Mitchell,, R. M. Chanock,, R. A. Shvedoff, and, C. E. Stewart. 1969. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:405421.
21. Kaufman, H. E. 2002. Can we prevent recurrences of herpes infections without antiviral drugs? The Weisenfeld Lecture. Invest. Ophthalmol. Vis. Sci. 43:13251329.
22. Kurane, I. 2007. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp. Immunol. Microbiol. Infect. Dis. 30:329340.
23. Liesegang, T. J. 1999. Classification of herpes simplex virus keratitis and anterior uveitis. Cornea 18:127143.
24. Liesegang, T. J. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:113.
25. Littaua, R.,, I. Kurane, and, F. A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144:31833186.
26. Mangada, M. M., and, A. L. Rothman. 2005. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J. Immunol. 175:26762683.
27. Martinez, F. D. 2003. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr. Infect. Dis. J. 22:S76S82.
28. Mathew, A., and, A. L. Rothman. 2008. Understanding the contribution of cellular immunity to Dengue disease pathogenesis. Immunol. Rev. 225:300313.
29. Metcalf, J. F., and, H. E. Kaufman. 1976. Herpetic stromal keratitis-evidence for cell-mediated immunopathogenesis. Am. J. Ophthalmol. 82:827834.
30. Oldstone, M. B., and, F. J. Dixon. 1969. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J. Exp. Med. 129:483505.
31. Olson,, J. K.,, J. L. Croxford,, and S. D. Miller. 2001. Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease. Viral Immunol. 14:227250.
32. Park, H.,, Z. Li,, X. O. Yang,, S. H. Chang,, R. Nurieva,, Y. H. Wang,, Y. Wang,, L. Hood,, Z. Zhu,, Q. Tian, and, C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:11331141.
33. Pepose,, J. S.,, D. A. Leib,, P. M. Stuart, and, D. L. Easty. 1996. p. 905–932. Herpes simplex virus disease. In J. S. Prepose,, G. Holland, and, K. Wilhelmus (ed.), Ocular Infection and Immunity. Mosby, St. Louis MO.
34. Pepose,, J. S.,, M. S. Nestor,, K. M. Gardner,, R. Y. Foos, and, T. H. Pettit. 1985. Composition of cellular infiltrates in rejected human corneal allografts. Graefes Arch Clin. Exp. Ophthalmol. 222:128133.
35. Perez-Yarza,, E. G.,, A. Moreno,, P. Lazaro,, A. Mejias, and, O. Ramilo. 2007. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr. Infect. Dis. J. 26:733739.
36. Robinson, W. E., Jr.,, D. C. Montefiori, and, W. M. Mitchell. 1988. Antibody-dependent enhancement of human immunodeficiency virus type 1 infection. Lancet 1:790794.
37. Saggioro,, F. P.,, M. A. Rossi,, M. I. Duarte,, C. C. Martin,, V. A. Alves,, M. L. Moreli,, L. T. Figueiredo,, J. E. Moreira,, A. A. Borges, and, L. Neder. 2007. Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J. Infect. Dis. 195:15411549.
38. Schountz, T.,, J. Prescott,, A. C. Cogswell,, L. Oko,, K. Mirowsky-Garcia,, A. P. Galvez, and, B. Hjelle. 2007. Regulatory T celllike responses in deer mice persistently infected with Sin Nombre virus. Proc. Natl. Acad. Sci. USA 104:1549615501.
39. Sen, N.,, A. Sen, and, E. R. Mackow. 2007. Degrons at the C terminus of the pathogenic but not the nonpathogenic hantavirus G1 tail direct proteasomal degradation. J. Virol. 81:43234330.
40. Shimeld, C.,, T. Hill,, B. Blyth, and, D. Easty. 1989. An improved model of recurrent herpetic eye disease in mice. Curr. Eye Res. 8:11931205.
41. Shresta,, S.,, K. L. Sharar,, D. M. Prigozhin,, P. R. Beatty, and, E. Harris. 2006. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80:1020810217.
42. Streilein, J. W.,, M. R. Dana, and, B. R. Ksander. 1997. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 18:443449.
43. Takada, A.,, H. Feldmann,, T. G. Ksiazek, and, Y. Kawaoka. 2003. Antibody-dependent enhancement of Ebola virus infection. J. Virol. 77:75397544.
44. Thomas, J.,, S. Gangappa,, S. Kanangat, and, B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158:13831391.
45. von Herrath, M. G., and, M. B. Oldstone. 1996. Virus-induced autoimmune disease. Curr. Opin. Immunol. 8:878885.
46. Youinou, P.,, J. Colin, and, C. Ferec. 1986. Monoclonal antibody analysis of blood and cornea T lymphocyte subpopulations in herpes simplex keratitis. Graefes Arch Clin. Exp. Ophthalmol. 224:131133.
47. Youinou, P.,, J. Colin, and, D. Mottier. 1985. Immunological analysis of the cornea in herpetic stromal keratitis. J. Clin. Lab. Immunol. 17:105106.
48. Zellweger, R. M.,, Pretwood,, T. R. and Shresta, S. 2010. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host & Microbe. 7:128139.

Tables

Generic image for table
TABLE 1

Examples of host and viral factors contributing to virus induced pathology

Citation: Jones C, Von Herrath M. 2011. Pathology and Pathogenesis of Virus Infections, p 383-389. In Kaufmann S, Rouse B, Sacks D (ed), The Immune Response to Infection. ASM Press, Washington, DC. doi: 10.1128/9781555816872.ch30

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error